Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Mawson Infrastructure Group Inc. Releases Preliminary Unaudited Results for Fourth Quarter and Fiscal Year 2025
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large…
FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in the Execution of the Genesis Plan
Press Release FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
January 13, 2026 07:05 ET | Source: Treace Medical Concepts, Inc. PONTE…
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
January 11, 2026 09:30 ET | Source: RxSight, Inc. ALISO VIEJO, Calif.,…
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
October 27, 2025 16:05 ET | Source: Pulmonx Corporation Glen French, member…
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
Smart Share Global Limited Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company from Hillhouse
August 15, 2025 16:15 ET | Source: Smart Share Global Limited SHANGHAI,…
